Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

CorMedix (CRMD) Assets Average: 2012-2025

Historic Assets Average for CorMedix (CRMD) over the last 10 years, with Sep 2025 value amounting to $501.7 million.

  • CorMedix's Assets Average rose 641.56% to $501.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $501.7 million, marking a year-over-year increase of 641.56%. This contributed to the annual value of $65.5 million for FY2022, which is 10.76% up from last year.
  • As of Q3 2025, CorMedix's Assets Average stood at $501.7 million, which was up 149.50% from $201.1 million recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Assets Average peaked at $501.7 million during Q3 2025, and registered a low of $58.1 million during Q2 2023.
  • Its 3-year average for Assets Average is $133.9 million, with a median of $77.0 million in 2023.
  • Per our database at Business Quant, CorMedix's Assets Average declined by 19.64% in 2022 and then skyrocketed by 641.56% in 2025.
  • CorMedix's Assets Average (Quarterly) stood at $72.2 million in 2021, then declined by 14.01% to $62.1 million in 2022, then climbed by 14.36% to $74.2 million in 2023, then decreased by 8.85% to $98.2 million in 2024, then soared by 641.56% to $501.7 million in 2025.
  • Its last three reported values are $501.7 million in Q3 2025, $201.1 million for Q2 2025, and $134.2 million during Q1 2025.